• Archer Pharmaceuticals Inc., of Sarasota, Fla., said an international research consortium led by researchers at Trinity College Dublin said they were recommended for funding for a large-scale European Phase III trial of Nilvadipine in Alzheimer's disease. The grant is awarded by the European Commission Seventh Framework Programme.